Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Pacira BioSciences: Targeting Sales >$1bn By 2025 Despite New Competitive Threat [Seeking Alpha]

Heron Therapeutics, Inc. (HRTX) 
Last heron therapeutics, inc. earnings: 3/2 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: herontherapeutics.gcs-web.com/investor-home
Company Research Source: Seeking Alpha
Summary Long-acting, local analgesic exparel earned Pacira $400m in revenues in 2019. Pacira has paid $120m to acquire MyoScience with up to $100m more in milestones payable to gain access to Iovera - a handheld cryoanalgesia device for chronic pain management. During the Q419 earnings call Pacira laid out plans to reach $1bn in revenues by 2025 and shrugged off likely competition from Heron Therapeutics' soon-to-be-approved exparel rival. Exparel and now Iovera's USP is non-opioid pain relief that can be used in outside-the-hospital settings thanks to Pacira's proprietary DepoFoam delivery system. Key to Pacira's success will be reducing operating costs of $400m whilst continuing to find new markets for its products. Analysts' rate Pacira a strong buy- I'm inclined to agree. Investment Thesis Pacira BioSciences ( PCRX The Centers for Disease Control and Prevention has reported that of 70,000 drug overdose deaths in the US in 2017, 48,000 were directly or indirectly caused by opioid-r Show less Read more
Impact Snapshot
Event Time:
HRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
HRTX alerts

from News Quantified
Opt-in for
HRTX alerts

from News Quantified